oral glp 1 agonist brand name Guide to GLP-1 Medications for Weight Loss and Diabetes brand name of semaglutide Semaglutide

while prior centrally-acting drugs posed risks of mood disorders and cardiovascular consequences, the primary adverse effects of GLP-1 receptor agonists are gastrointestinal and often minor or temporary (Zheng et al

Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Gunawardene P, et al

Strength training can help preserve muscle mass during treatment and prevent weight regain after stopping the medication

The semaglutide withdrawal symptoms guide and tirzepatide tapering guide provide strategies for safely reducing or discontinuing medication

Efficacy and safety of lixisenatide once-daily versus placebo in patients with type 2 diabetes mellitus insufficiently controlled on met-formin (GetGoal-F1) [Abstract] Diabetologia

Commissioned by the World Health Organization, the reviews will contribute to upcoming WHO guidelines on the use of GLP-1 receptor agonists for treating obesity